Terug
Dagbereik
€ 237,41
€ 243,98
52-Weeksbereik
€ 187,43
€ 322,34
Volume
590.623
50D / 200D Gem.
€ 246,84
/
€ 252,44
Vorige Slotkoers
€ 237,03
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 35,2 | 0,4 |
| P/B | 5,5 | 2,9 |
| ROE % | 16,9 | 3,7 |
| Net Margin % | 16,1 | 3,8 |
| Rev Growth 5Y % | 2,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue grew 2,08% annually over 5 years — modest growth
ROE of 16,85% — decent returns on equity
Net margin of 16,06% shows strong profitability
Debt/Equity of 0,13 — conservative balance sheet
Generating 468,90M in free cash flow
P/E of 35,22 — premium valuation
Groei
Revenue Growth (5Y)
2,08%
Revenue (1Y)6,26%
Earnings (1Y)0,20%
FCF Growth (3Y)6,36%
Kwaliteit
Return on Equity
16,85%
ROIC12,89%
Net Margin16,06%
Op. Margin20,09%
Veiligheid
Debt / Equity
0,13
Current Ratio3,02
Interest Coverage1029,00
Waardering
P/E Ratio
35,22
P/B Ratio5,47
EV/EBITDA27,55
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,26% | Revenue Growth (3Y) | 2,06% |
| Earnings Growth (1Y) | 0,20% | Earnings Growth (3Y) | -8,79% |
| Revenue Growth (5Y) | 2,08% | Earnings Growth (5Y) | -7,06% |
| Profitability | |||
| Revenue (TTM) | 3,07B | Net Income (TTM) | 493,70M |
| ROE | 16,85% | ROA | 11,56% |
| Gross Margin | 35,89% | Operating Margin | 20,09% |
| Net Margin | 16,06% | Free Cash Flow (TTM) | 468,90M |
| ROIC | 12,89% | FCF Growth (3Y) | 6,36% |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 3,02 |
| Interest Coverage | 1029,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 35,22 | P/B Ratio | 5,47 |
| P/S Ratio | 5,66 | PEG Ratio | 34,00 |
| EV/EBITDA | 27,55 | Dividend Yield | 0,00% |
| Market Cap | 17,39B | Enterprise Value | 17,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,07B | 2,89B | 2,95B | 2,89B | 2,83B |
| Net Income | 493,70M | 492,70M | 593,40M | 585,90M | 661,80M |
| EPS (Diluted) | 6,80 | 6,69 | 7,88 | 7,73 | 8,67 |
| Gross Profit | 1,10B | 1,00B | 1,13B | 1,14B | 1,17B |
| Operating Income | 617,40M | 594,60M | 710,90M | 763,50M | 758,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,27B | 3,64B | 3,83B | 3,62B | 3,31B |
| Total Liabilities | 1,09B | 961,10M | 948,50M | 931,90M | 978,40M |
| Shareholders' Equity | 3,18B | 2,68B | 2,88B | 2,68B | 2,34B |
| Total Debt | 416,70M | 305,30M | 309,00M | 317,90M | 325,30M |
| Cash & Equivalents | 791,30M | 484,60M | 853,90M | 894,30M | 762,60M |
| Current Assets | 1,98B | 1,54B | 1,94B | 1,92B | 1,74B |
| Current Liabilities | 654,90M | 550,40M | 671,80M | 519,00M | 594,10M |